Evidence map›Paper›PMID 39553131›Full record

ArticleCureus2024

Axillary Lymph Node Malignant Melanoma of Unknown Primary Origin: A Case Report From Japan.

Takeshi Nomura, Gan Muneuchi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Takeshi NomuraPublic Health, Tokyo Medical and Dental University, Tokyo, JPN.
Gan MuneuchiPlastic and Reconstructive Surgery, Osaka Saiseikai Nakatsu Hospital, Osaka, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant melanoma of unknown primary origin (MUP) is a rare disease predominantly reported in Caucasian individuals. In this paper, we report a rare case of MUP. We treated a 75-year-old Japanese man with an MUP localized to the axillary lymph nodes. The primary tumor could not be identified despite available investigations. We performed radical lymph node dissection and administered postoperative adjuvant therapy using the molecular-targeted drugs dabrafenib and trametinib. Ten months after surgery, the patient experienced a favorable clinical course with no recurrence or complications from surgery or medication. The frequency and clinical characteristics of malignant melanoma differ among ethnic groups, and very few reports of MUP have been documented in East Asia.

Indexed as

axillary lymph nodes dissectioncase reportmalignant melanomamelanoma of unknown primaryrare disease

Identifiers

PMID39553131
PMCPMC11569934

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.